Tenofovir alafenamide fumarate use for HIV pre-exposure prophylaxis and weight gain. [PDF]
Shi F, Xia H, Weissman S, Li X, Yang X.
europepmc +1 more source
The prognosis characteristics of HIV/HBV co-infection after antiviral therapy: a comprehensive review. [PDF]
Peng A +10 more
europepmc +1 more source
Long-Term Outcomes of Patients Who Receive a Liver Transplant for Hepatitis B With Limited Use of Hepatitis B Immunoglobulin. [PDF]
Roldan GA, Loon E, Lake J, Lim N.
europepmc +1 more source
Assessment of the risk of discontinuation of tenofovir disoproxil fumarate after delivery and the benefit of continued treatment in patients with immune tolerance. [PDF]
Liang H +10 more
europepmc +1 more source
Real-World Outcomes of Antiretroviral Therapy in People Living With HIV in Saudi Arabia: A Three-Year Observational Cohort Study From a Tertiary Care Center. [PDF]
Alsaeed A.
europepmc +1 more source
Distribution and efficacy of dolutegravir-based regimens in the main HIV outpatient care in Caracas, Venezuela. [PDF]
Alvarado-Bruzual MF +8 more
europepmc +1 more source
Postpartum maternal monitoring for renal safety related to tenofovir exposure during breastfeeding in the PROMISE 1077BF randomized trial. [PDF]
Baltrusaitis K +15 more
europepmc +1 more source
A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens. [PDF]
Dickinson L +7 more
europepmc +1 more source

